Health Canada has permitted Trimel Pharmaceuticals' to enroll patients in Canada for the Tefina Phase II Ambulatory study. The double-blinded, placebo-controlled study will enroll 240 pre-menopausal women patients with female orgasmic ...
Tags: Trimel, Tefina, female orgasmic disorder